{"entity":{"id":"anchordx","kind":"company","name":"AnchorDx","aka":["AnchorDx Medical Co., Ltd."],"tldr":"A Guangzhou company making DNA methylation tests in blood and urine, which announced a six-cancer blood test, Aurora, in 2020.","summary":"AnchorDx Medical, of Guangzhou, with a US entity in Fremont, California, according to its authors' affiliations, has published methylation assays for lung, bladder, kidney and colorectal cancer and a two-cancer colorectal and gastric study. It announced Aurora, a methylation blood test for six cancers, in June 2020.","asOf":"2026-11-03","links":[{"label":"Lei et al., American Journal of Cancer Research 2024","url":"https://doi.org/10.62347/TPTQ3682"}],"tags":[],"related":[],"cancers":[],"sections":["early-detection","diagnostics"],"technologies":["mced","liquid-biopsy","cfdna-methylation-testing"],"targets":[],"drugs":["anchordx-aurora"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Guangzhou","country":"CN","companyType":"diagnostics","investors":[],"funding":[]},"route":"/companies/anchordx/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"cfdna-methylation-testing","kind":"technology","name":"Cell-free DNA methylation tests","route":"/technologies/cfdna-methylation-testing/"},{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"},{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"}],"drug":[{"id":"anchordx-aurora","kind":"drug","name":"Aurora (AnchorDx)","route":"/drugs/anchordx-aurora/"}]}}